David Berry

                                                                David A. Berry, MD, PhD, Partner
                                                                            Flagship Ventures
                                                               One Memorial Drive, 7th Floor
                                                                        Cambridge, MA 02142
                                                                                   617-218-1653
                                                                   www.flagshipventures.com

David Berry joined Flagship in 2005 where he focuses on innovating, entrepreneuring, and investing in new ventures in life sciences and sustainability.  He is a founder of Flagship portfolio companies LS9, Joule Unlimited, Eleven Biotherapeutics, Seres Health, Pronutria, among others.  David was founding CEO of Joule and Pronutria.  David previously completed his combined MD-PhD from Harvard Medical School and the MIT Biological Engineering Division in just over 5 years. He has been recognized with over 50 awards and honors as an innovator including receiving the prestigious Lemelson-MIT Student Prize for invention and innovation, being named the Innovator of the Year by Technology Review, and being selected by the US State Department as 1 of 12 Innovators Helping to Reshape Realty.  David previously served on the MIT Corporation, its Board of Trustees, and currently serves on the boards of multiple not-for-profits in education and the arts, and has been appointed to the United Nations Sustainable Development Solution Network Leadership Council.